News Related to Dong-A ST

Related coverage linked through entity extraction aliases.

Pharmaceutical companies in South Korea expand digital healthcare businesses

Apr 14, 2026

South Korean pharmaceutical companies are expanding digital healthcare businesses as they seek new revenue sources. The domestic market recorded 7.7409 trillion won in sales in 2024, while companies including Daewoong Pharmaceutical, Dong-A ST, Handok and Yuhan are advancing products and investments.

Korean Biotechs to Present Next-Gen Cancer Therapies at AACR Meeting

Apr 08, 2026

Korean biotech firms will present next-generation cancer therapies at the AACR meeting, including CAR-T platforms for solid tumors, mRNA-based treatments, radiopharmaceuticals, and bispecific antibody ADCs. Companies like AbClon, Verismo Therapeutics, Hanmi Pharmaceutical, and SK Biopharmaceuticals will showcase their latest research.